1887

Abstract

Summary

Tumour necrosis factor (TNF) induces antiviral activity in HEp-2 cells. Virus yield reduction assays with vesicular stomatitis virus as challenging virus demonstrated that the antiviral state was more pronounced in confluent cultures under low serum conditions. A significant enhancement of the antiviral state was obtained by combining TNF with low concentrations of either interferon (IFN)-β1 or IFN-γ. The reduction in virus yield was significantly higher than that expected from summation of the independent antiviral activities of either substance alone, i.e. TNF and IFN acted synergistically as antiviral agents. Synergism of TNF with IFN-β or IFN-γ appeared to be mediated by different pathways, since different requirements for pretreatment and different effects on oligo-2′,5′-adenylate synthetase (2-5AS) induction were observed. Induction of 2–5AS by TNF could be shown to be an indirect event that was sensitive to an antiserum against natural IFN-β1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-12-3113
1988-12-01
2022-07-01
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/12/JV0690123113.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-12-3113&mimeType=html&fmt=ahah

References

  1. CARSWELL E. A., OLD L. J., KASSEL R. L., GREEN S., FIORE N., WILLIAMSON B. 1975; An endotoxin-induced serum factor that causes necrosis of tumors. Proceedings of the National Academy of Sciences, U.S.A 72:3666–3670
    [Google Scholar]
  2. CHIRGWIN J. M., PRZYBYLA A. E., MACDONALD R. J., RUTTER W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
    [Google Scholar]
  3. CZARNIECKI C. W., FENNIE C. W., POWERS D. P., ESTELL D. A. 1984; Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. Journal of Virology 49:490–496
    [Google Scholar]
  4. DEFILIPPI P., POUPART P., TAVERNIER J., FIERS W., CONTENT J. 1987; Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proceedings of the National Academy of Sciences, U.S.A 84:4557–4561
    [Google Scholar]
  5. DINARELLO C. A., CANNON J. G., WOLFF S. M., BERNHEIM H. A., BEUTLER B., CERAMI A., FIGARI I. S., PALLADINO M. A. JR, O’CONNOR J. V. 1986; Tumor necrosis factor (cachectin) is an endogeneous pyrogen and induces production of interleukin 1. Journal of Experimental Medicine 163:1433–1450
    [Google Scholar]
  6. FALTYNEK C R., MCCANDLESS S., CHEBATH J., BAGLIONI C. 1985; Different mechanisms for activation of gene transcription by interferons β and γ. Virology 144:173–180
    [Google Scholar]
  7. FEINBERG A. P., VOGELSTEIN B. 1983; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 132:6–13
    [Google Scholar]
  8. FRAKER P. J., SPECK J. C. 1978; Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrochloro-3α,6α-diphenylglycoluril. Biochemical and Biophysical Research Communications 80:849–857
    [Google Scholar]
  9. FRANSEN L., MÜLLER R., MARMENOUT A., TAVERNIER J., VAN DER HEYDEN J., KAWASHIMA E., CHOLLET A., TIZARD R., VAN HEUWERSWYN H., VAN VLIET A., RUYSSCHAERT M., FIERS W. 1985; Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Research 13:4417–4429
    [Google Scholar]
  10. KLEBANOFF S. J., VADAS M. A., HARLAN J. M., SPARKS L. H., GAMBLE J. R., AGOSTI J. M., WALTERSDORPH A. M. 1986; Stimulation of neutrophils by tumor necrosis factor. Journal of Immunology 136:4220–4225
    [Google Scholar]
  11. KNIGHT M., CAYLEY P. J., SILVERMAN R. H., WRESCHNER D. H., GILBERT C. S., BROWN R. E., KERR I. M. 1980; Radioimmune, radiobinding and HPLC analysis of 2·5 A and related oligonucleotides from intact cells. Nature, London 288:189–192
    [Google Scholar]
  12. KOHASE M., HENRIKSEN-DE STEFANO D., MAY L. T., VILCEK J., SEHGAL P. B. 1986; Induction of β2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 45:659–666
    [Google Scholar]
  13. MANIATIS T., FF.ITSCH E. F., SAMBROOK J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  14. MARMENOUT A., FRANSEN L., TAVERNIER J., VAN DER HEYDEN J., TIZARD R., KAWASHIMA E., SHAW A., JOHNSON M., SEMON D., MÜLLER R., RUYSSCHAERT M., VAN VLIET A., FIERS W. 1985; Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. European Journal of Biochemistry 152:515–522
    [Google Scholar]
  15. MESTAN J., DIGEL W., MITTNACHT S., HILLEN H., BLOHM D., MÖLLER A., JACOBSEN H., KIRCHNER H. 1986; Antiviral effects of recombinant tumour necrosis factor in vitro. Nature, London 323:816–819
    [Google Scholar]
  16. NAWROTH P. P., BANK I., HANDLEY D., CASSIMERIS J., CHESS L., STERN D. 1986; Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1. Journal of Experimental Medicine 163:1363–1375
    [Google Scholar]
  17. OLD L. J. 1985; Tumor necrosis factor (TNF). Science 230:630–632
    [Google Scholar]
  18. OLESZAK E., STEWART W. E. 1985; Potentiation of the antiviral and anticellular activities of interferons by mixtures of huIFN-γ and huIFN-α or huIFN-β. Journal of Interferon Research 5:361–371
    [Google Scholar]
  19. PENNICA D., NEDWIN G. E., HAYFLICK J. S., SEEBURG P. H., DERYNCK R., PALLADINO M. A., KOHR W. J., AGGARWAL B. B., GOEDDEL D. V. 1984; Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature, London 312:724–729
    [Google Scholar]
  20. SHALABY M. R., AGGARWAL B. B., RINDERKNECHT E., SVEDERSKY L. P., FINKLE B. S., PALLADINO M. A. JR 1985; Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors. Journal of Immunology 135:2069–2073
    [Google Scholar]
  21. SHIRAI T., YAMAGUCHI H., ITO H., TODD C. W., WALLACE R. B. 1985; Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature, London 313:803–806
    [Google Scholar]
  22. SILBERSTEIN D. S., DAVID J. R. 1986; Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae. Proceedings of the National Academy of Sciences, U.S.A 83:1055–1059
    [Google Scholar]
  23. SILVERMAN R. H., WATLING D., BALKWILL F. R., TROWSDALE J., KERR I. M. 1982; The ppp(A2′p)nA and protein kinase systems in wild-type and interferon-resistant Daudi cells. European Journal of Biochemistry 126:333–341
    [Google Scholar]
  24. SUGARMAN B. J., AGGARWAL B. B., HASS P. E., FIGARI I. S., PALLADINO M. A. JR, SHEPARD H. M. 1985; Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945
    [Google Scholar]
  25. TSUJIMOTO M., YIP Y. K., VILCEK J. 1986; Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. Journal of Immunology 136:2441–2444
    [Google Scholar]
  26. VAN DAMME J., DE LEY M., VAN SNICK J., DINARELLO C. A., BILLIAU A. 1987; The role of IFN-α1 and the 26-kDa protein (interferon-β2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. Journal of Immunology 139:1867–1872
    [Google Scholar]
  27. VILCEK J., PALOMBELLA V. J., HENRYKSEN-DESTEFANO D., SWENSON C, FEINMAN R., HIRAI M., TSUJIMOTO M. 1986; Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. Journal of Experimental Medicine 163:632–643
    [Google Scholar]
  28. WANG A. M., CREASEY A. A., LADNER M. B., LIN L. S., STRICKLER J., VAN ARSDELL J. N., YAMAMOTO R., MARK D. F. 1985; Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149–228
    [Google Scholar]
  29. WONG G. H. W., GOEDDEL D. V. 1986; Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature, London 323:819–822
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-12-3113
Loading
/content/journal/jgv/10.1099/0022-1317-69-12-3113
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error